GABAPENTIN | A078428 | AMNEAL PHARMACEUTICALS NY LLC
Highest NADAC/Unit
$0.0428
per ea
Lowest NADAC/Unit
$0.0219
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 65162010310GABAPENTIN 400 MG CAPSULE | $0.0428 | EA | Generic | — | 2026-10-21 |
| 65162010350GABAPENTIN 400 MG CAPSULE | $0.0428 | EA | Generic | — | 2026-10-21 |
| 65162010211GABAPENTIN 300 MG CAPSULE | $0.0328 | EA | Generic | — | 2026-10-21 |
| 65162010210GABAPENTIN 300 MG CAPSULE | $0.0328 | EA | Generic | — | 2026-10-21 |
| 65162010250GABAPENTIN 300 MG CAPSULE | $0.0328 | EA | Generic | — | 2026-10-21 |
| 65162010111GABAPENTIN 100 MG CAPSULE | $0.0219 | EA | Generic | — | 2026-10-21 |
| 65162010150GABAPENTIN 100 MG CAPSULE | $0.0219 | EA | Generic | — | 2026-10-21 |
| 65162010110GABAPENTIN 100 MG CAPSULE | $0.0219 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.